|Home||» Products||» Pharmaceutical Medicine||» Arixtra|
Generic Name: fondaparinux (Subcutaneous route)
Epidural or spinal hematomas may occur in patients who are anticoagulated with low molecular weight heparins (LMWH), heparinoids, or fondaparinux sodium and are receiving neuraxial anesthesia or undergoing spinal puncture. These hematomas may result in long-term or permanent paralysis. Consider these risks when scheduling patients for spinal procedures. Factors that can increase the risk of developing epidural or spinal hematomas in these patients include:
use of indwelling epidural catheters
concomitant use of other drugs that affect hemostasis, such as non-steroidal antiinflammatory drugs (NSAIDs), platelet inhibitors, or other anticoagulants
a history of traumatic or repeated epidural or spinal puncture
a history of spinal deformity or spinal surgery
Monitor patients frequently for signs and symptoms of neurologic impairment. If neurologic compromise is noted, urgent treatment is necessary.
Consider the benefit and risks before neuraxial intervention in patients anticoagulated or to be anticoagulated for thromboprophylaxis .
Fondaparinux is used to prevent a type of blood clot called deep vein thrombosis(DVT), which can lead to blood clots in the lungs (pulmonary embolism). A DVTcan occur after certain types of surgery. Fondaparinux is also used together withwarfarin (Coumadin, Jantoven) to treat DVT, including pulmonary embolism